Search Results for keywords:"Foreign-Trade Zone 35"

Found 2 results
Skip to main content

Search Results: keywords:"Foreign-Trade Zone 35"

  • Type:Notice
    Citation:90 FR 13732
    Reading Time:less than a minute

    PCI Pharma Services submitted a proposal to the Foreign-Trade Zones (FTZ) Board on November 21, 2024, to begin production activities at their facilities in Croydon and Philadelphia, Pennsylvania, within FTZ Subzone 35L. This notification adhered to the FTZ Board's regulations, and the public had the opportunity to comment on it as announced in the Federal Register on November 29, 2024. On March 21, 2025, the FTZ Board decided that no further review was needed, authorizing the proposed production activities in accordance with FTZ regulations.

    Simple Explanation

    PCI Pharma Services wants to make medicines in two places in Pennsylvania, and a special group that helps with trade said it's okay for them to start doing this.

  • Type:Notice
    Citation:90 FR 9887
    Reading Time:about a minute or two

    Piramal Pharma Solutions has notified the Foreign-Trade Zones Board about proposed production activities at their facility in Philadelphia, within FTZ 35. They plan to produce bempedoic acid tablets and bempedoic oral suspension. The public is encouraged to submit comments on this proposal by March 31, 2025. More details are available on the Board's website, and interested parties can contact Kolade Osho for further information.

    Simple Explanation

    Piramal Pharma Solutions wants to make a new medicine in Philadelphia and they are letting people know about it, so folks can say what they think. People can send their thoughts online before the end of March to help decide if it's a good idea.